Last reviewed · How we verify
systematic therapy
At a glance
| Generic name | systematic therapy |
|---|---|
| Also known as | chemotherapy, targeted therapy or immune checkpoint inhibitor |
| Sponsor | Jian Zhang,MD |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Tele-video to Improve Daily Activity 2.0 (NA)
- Systemic Immune-Inflamation Index and Mortality in ICU Patients
- Effects of Exercises and Electrical Current Application Aiming to Strengthen Neck and Shoulder Blades Muscles on Symptoms of a Pinched Nerve in the Neck (NA)
- Effect of Ambient Temperature on Blood Glucose and Insulin Absorption in Adults With Type 1 Diabetes (NA)
- Trial-based Economic Evaluation of a Mobile Health Intervention for Individuals With Chronic Non-specific Low Back Pain (NA)
- MDT-Based Nursing for Small Cell Lung Cancer During Chemo-Immunotherapy (NA)
- SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer
- Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- systematic therapy CI brief — competitive landscape report
- systematic therapy updates RSS · CI watch RSS
- Jian Zhang,MD portfolio CI